Market Exclusive

Analyst Downgrades – NASDAQ:NKTR – Nektar Therapeutics (NASDAQ:NKTR) Stock Gets Downgraded By HC Wainwright from Buy ➝ Neutral to

Analyst Ratings For NASDAQ:NKTR – Nektar Therapeutics (NASDAQ:NKTR)

Today, NASDAQ:NKTR – Nektar Therapeutics (NASDAQ:NKTR) stock was downgraded by HC Wainwright from Buy ➝ Neutral to with a price target of $54.00.

Some recent analyst ratings include

Recent Insider Trading Activity For NASDAQ:NKTR – Nektar Therapeutics (NASDAQ:NKTR)
NASDAQ:NKTR – Nektar Therapeutics (NASDAQ:NKTR) has insider ownership of 4.31% and institutional ownership of 90.84%.

Recent Trading Activity for NASDAQ:NKTR – Nektar Therapeutics (NASDAQ:NKTR)
Shares of NASDAQ:NKTR – Nektar Therapeutics closed the previous trading session at 53.31 down -0.83 1.53% with 52.84000015258789 shares trading hands.

Exit mobile version